Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 15, 2026
Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study
Halet Türkantoz, Christiane Dobbelstein, Richard Greil, et al.
Blood
|
April 19, 2022
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
Frank W G Leebeek, Flora Peyvandi, Miguel Escobar, et al.
Xenotransplantation
|
May 9, 2014
Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation
Wolf Ramackers, Lars Friedrich, Johannes Klose, et al.
Plos Genetics
|
April 9, 2020
Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B
Simon Krooss, Sonja Werwitzke, Johannes Kopp, et al.
Plos Genetics
|
January 28, 2021
Correction: Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B
Simon Krooss, Sonja Werwitzke, Johannes Kopp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 8, 2018
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial
Steven R Lentz, Dragana Janic, Kaan Kavakli, et al.
Haematologica
|
May 9, 2020
International recommendations on the diagnosis and treatment of acquired hemophilia A
Andreas Tiede, Peter Collins, Paul Knoebl, et al.
Thrombosis Research
|
March 28, 2026
Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study
Raza Alikhan, May Nour, Andreas Tiede, et al.
Hamostaseologie
|
December 21, 2022
Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)
Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, et al.
Hamostaseologie
|
December 14, 2022
[Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH)]
Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 15, 2026
Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study
Halet Türkantoz, Christiane Dobbelstein, Richard Greil, et al.
Blood
|
April 19, 2022
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
Frank W G Leebeek, Flora Peyvandi, Miguel Escobar, et al.
Xenotransplantation
|
May 9, 2014
Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation
Wolf Ramackers, Lars Friedrich, Johannes Klose, et al.
Plos Genetics
|
April 9, 2020
Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B
Simon Krooss, Sonja Werwitzke, Johannes Kopp, et al.
Plos Genetics
|
January 28, 2021
Correction: Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B
Simon Krooss, Sonja Werwitzke, Johannes Kopp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 8, 2018
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial
Steven R Lentz, Dragana Janic, Kaan Kavakli, et al.
Haematologica
|
May 9, 2020
International recommendations on the diagnosis and treatment of acquired hemophilia A
Andreas Tiede, Peter Collins, Paul Knoebl, et al.
Thrombosis Research
|
March 28, 2026
Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study
Raza Alikhan, May Nour, Andreas Tiede, et al.
Hamostaseologie
|
December 21, 2022
Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)
Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, et al.
Hamostaseologie
|
December 14, 2022
[Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH)]
Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, et al.
Page
of 13